PM360 Hillary M. Titus, Director of External Communications, BioReference Laboratories, Inc. As the world’s leading diagnostics labs raced to develop effective COVID-19 testing programs, BioReference Laboratories’ existing proprietary technology was already far ahead of the competition. However, the small lab was virtually unknown. In order to launch new testing services, BioReference had to become part […]
Search Results for: log
18
Oct
Oct
In honor of Breast Cancer Awareness Month, Terri offers her perspective on her breast cancer treatment, the positive attitude and silver-lining she discovered through her journey.
06
Oct
Oct
ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]
20
Sep
Sep
As data from public health entities continues to emerge about COVID-19 and the Delta variant, we have learned it is more infectious and leading to increased transmissibility when compared with other variants. With the Delta variant accounting for more than 93% of new COVID-19 cases and being more than 2x as contagious as previous variants, according […]
03
Sep
Sep
September is Prostate Cancer Awareness Month! Other than skin cancer, prostate cancer is the most common cancer in American men. 1 The American Cancer Society’s estimates for prostate cancer in the United States for 2021 are: 248,530 new cases of prostate cancer 34,130 deaths from prostate cancer About 1 in 8 men will be diagnosed […]
Press Release
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
26
Aug
Aug
New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Press Release
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
16
Aug
Aug
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
12
Aug
Aug
This month, we are striving to bring awareness to Spinal Muscular Atrophy (SMA), a serious inherited condition caused by changes in the SMN1 gene, which controls motor neurons in the spinal cord and brainstem. Symptoms can begin prior to six months of age, in childhood, or, more rarely, in adulthood. In the most common form […]
